1992
DOI: 10.1038/bjc.1992.76
|View full text |Cite
|
Sign up to set email alerts
|

Transcriptional down-regulation of c-myc in human prostate carcinoma cells by the synthetic androgen mibolerone

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
24
0

Year Published

1993
1993
2005
2005

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 41 publications
(27 citation statements)
references
References 51 publications
3
24
0
Order By: Relevance
“…This seemed reasonable since the incomplete disappearance of hAR RNA even after prolonged hormone administration could reflect a differential effect of MIB on individual RNA start sites. We have recently observed differential effects of MIB on the promoter usage of the c-myc protooncogene in LNCaP cells (34). Figure 2A confirms the results of previous reports showing that hAR gene expression in several cell types uses two principal mRNA initiation sites located 1115 and 1126 nucleotides in front of the ATG translation initiation codon.…”
Section: Ar Rnas Starting From Different Transcription Initiation Sitsupporting
confidence: 80%
See 1 more Smart Citation
“…This seemed reasonable since the incomplete disappearance of hAR RNA even after prolonged hormone administration could reflect a differential effect of MIB on individual RNA start sites. We have recently observed differential effects of MIB on the promoter usage of the c-myc protooncogene in LNCaP cells (34). Figure 2A confirms the results of previous reports showing that hAR gene expression in several cell types uses two principal mRNA initiation sites located 1115 and 1126 nucleotides in front of the ATG translation initiation codon.…”
Section: Ar Rnas Starting From Different Transcription Initiation Sitsupporting
confidence: 80%
“…possible participation of the AR protein in hAR RNA down-regulation by MIB, we tried to antagonize the androgen effect by the simultaneous addition of AR blocking agents (antiandrogens). The steroidal antiandrogen cyproterone acetate (CA) as well as the nonsteroidal antiandrogen hydroxy flutamide (Flu-OH) were recently shown to effectively prevent the inhibitory action of MIB on proliferation and c-myc expression in LNCaP cells (34,35) while not exerting any effect when administered alone. Due to the relatively low affinity of antiandrogens for the AR a several hundredfold molar excess over the androgen is required for effective blockage of androgen action (36).…”
Section: Ar Rnas Starting From Different Transcription Initiation Sitmentioning
confidence: 99%
“…On the other hand, in various cell types and tissues, c-myc expression has been shown to be regulated by sex-steroid hormones (Schuchard et al 1993). For example, testosterone treatment reduces c-myc mRNA level, in vivo, in the rat ventral prostate (Quarmby et al 1987) and, in vitro, in human prostatic cells (Wolf et al 1992).…”
Section: Introductionmentioning
confidence: 99%
“…43 This transcription factor is involved in differentiation and the level of C-MYC mRNA is higher in proliferating cells. 44 Levels fall dramatically when cells withdraw from the cell cycle or undergo terminal differentiation. 44 A gene that is involved in these cellular processes might be involved in tumourigenesis if its function is altered, particularly by amplification.…”
Section: The C-myc Oncogenementioning
confidence: 99%
“…44 Levels fall dramatically when cells withdraw from the cell cycle or undergo terminal differentiation. 44 A gene that is involved in these cellular processes might be involved in tumourigenesis if its function is altered, particularly by amplification. A number of studies have shown that C-MYC mRNA is elevated in PC, compared to BPH or normal prostate tissue, and there tends to be enhanced expression with higher-grade tumours.…”
Section: The C-myc Oncogenementioning
confidence: 99%